Home › Studies › PRJNA885489
PRJNA885489 SRP400421

Gut microbiome and drug exposures in allo-HCT patients, USA

The associations between drug exposures and the intestinal microbiome in allo-HCT patients

558 fecal samples from allogeneic hematopoietic cell transplant (allo-HCT) patients in New York, USA, studied to assess associations between drug exposures, intestinal microbiome dynamics, and clinical outcomes using the PARADIGM computational method. machine-written summary

558 samples · 932 runs · US · Age unknown · 2022 · 6.17 Gbp / sample

Sources
✓Sequence archive 2,893✓Abstract / description 1,116○Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive2,893 sample values (country, latitude, location region, longitude, subject id, timepoint)
✓ Abstract / description1,116 sample values (health condition, health condition detail)
○ Full textread; no usable statement or table · PMC10390075
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
unknown558
Condition
transplant_or_immunocompromised558
Country
US558
Body site
primary558
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 2 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 3 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 32 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 500 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 21 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 5.83 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

122 of 351 people sampled more than once (329 samples; median 2, up to 16 per person). Schedule stated by the source: “Serial fecal samples collected at multiple days relative to transplant (DayRelativeToNearestHCT/bmtday, e.g. -7 to 160)”.

How longitudinal and relatedness information is derived

Community composition
Enterococcus_B 19.4%Akkermansia 6.3%Streptococcus 5.0%Klebsiella 4.4%Phocaeicola 3.5%Bacteroides 3.3%Blautia_A 3.3%Escherichia 3.2%Enterocloster 2.5%Blautia 2.5%Mediterraneibacter 2.5%Clostridium_AQ 2.2%not assigned to a genus 3.2%other genera 38.9%

Genera, mean relative abundance over 516 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country558 100%558
health_condition558 100%558
subject_id558 100%558
detailed_location558 100%
health_condition_detail558 100%558
latitude558 100%558
location_region558 100%558
longitude558 100%558
timepoint_label103 18%103
Papers (1)
  • High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. 2023 PMID 37295406 PMC10390075 own_data
Details
Archive description

This study investigated the associations between drug exposures, the intestinal microbiome and clinical outcomes in allo-HCT patients by developing a novel computational method called PARADIGM (PARameters Associated with DynamIcs of Gut Microbiome).

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.70. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • host study.title · “allo-HCT patients”
  • body site study.title · “the intestinal microbiome”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN07491315countryUSR10.90sample.attr.geo_loc_nameUSA:New York
SAMN07491315health_conditiontransplant_or_immunocompromisedR40.50paper.abstractpatients undergoing allogeneic hematopoietic cell transplantation
SAMN07491315health_condition_detailpatients undergoing allogeneic hematopoietic cell transplantationR40.50paper.abstractpatients undergoing allogeneic hematopoietic cell transplantation
SAMN07491315latitude40.7641R10.90biosample.attribute:lat_lon40.7641 N 73.9568 W
SAMN07491315location_regionNew YorkR10.85biosample.attribute:geo_loc_nameUSA:New York
SAMN07491315longitude-73.9568R10.90biosample.attribute:lat_lon40.7641 N 73.9568 W
SAMN07491315subject_id1064R10.85sample.attr.patient_id1064
SAMN13270437subject_id1588R10.70sample.name_rule:alias1588E
SAMN12007085timepoint_label-7R10.85sample.attr.bmtday-7
Sequencing

932 runs over 932 samples · mean 6.57 Gbp per run (median 6.17 Gbp, total 6,119.06 Gbp; 932 runs with a base count) · layout PAIRED 932 · platform ILLUMINA 932 · models Illumina NovaSeq 6000 (517), Illumina HiSeq 4000 (406), Illumina HiSeq 2500 (9) · 91% of runs with a Sandpiper profile · first public 2022-10-15 – 2022-11-02

Authors (0)

No author record.

Downloads

PRJNA885489.csv.gz (15.4 KB) · parquet (92.4 KB) — all 558 samples, every field with route and confidence · PRJNA885489_determinations.csv.gz (31.0 KB) — 4,009 evidence rows

Samples (558 · every field this project has values for · hover a cell for its source)
Loading the sample table…